SGRY
Surgery Partners, Inc.
NASDAQ · Healthcare · Medical - Care Facilities · US
$23.22
+0.41%Year over year
Reported trailing growth
- Revenue
- +4.0%
- EBITDA
- +81.4%
- EBIT
- +10.7%
- EPS
- +51.7%
- Free cash flow
- +7.0%
- Operating cash flow
- -2.2%
Forward estimates
Based on analyst estimates
- Revenue
- -9.0%
- EBITDA
- -30.1%
- EPS
- +163.9%
Three-year CAGR
- Revenue
- +9.2%
- EBITDA
- +7.1%
- EBIT
- +4.1%
- Net income
- +53.7%
- EPS
- +54.1%
- Free cash flow
- +35.7%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026